TruScreen Group Ltd. (AU:TRU) has released an update.
TruScreen Group Ltd has kick-started a significant commercial rollout of their cervical cancer screening devices in Vietnam with a first major order from Gorton Health Services, valued at approximately NZ$100,000. The initial deployment includes 10 devices and 1,800 single-use sensors, which will be distributed across 64 leading hospitals as part of Vietnam’s efforts to improve early detection and management of cervical cancer. This move follows TruScreen’s inclusion in the Vietnamese Ministry of Health Technical List and is expected to continue expanding throughout 2024 and into 2025.
For further insights into AU:TRU stock, check out TipRanks’ Stock Analysis page.
